Showing results (1-10 of 483) with videos related to
Sort By:
Pageof 49
Wiener Klinische Wochenschrift|July 15, 1988
[Liver function parameters and fibrinogen in intra-arterial and intravenous PGE1 infusion]H Sinzinger, P FitschaInternational Journal of Sports Medicine|December 1, 1986
Jogging causes a significant increase in platelet sensitivity to prostacyclinH Sinzinger, P FitschaWiener Klinische Wochenschrift|January 18, 1985
[Defects in the prostaglandin system. I. Familial total plasma factor deficiency]H Sinzinger, P FitschaWiener Klinische Wochenschrift|November 4, 1988
[Defects in the prostaglandin system. VII. (Generalized, inherited [?]) cyclooxygenase defect]P Fitscha, H SinzingerJournal of Cardiovascular Pharmacology|January 1, 1992
Antiatherosclerotic actions of isradipineH Sinzinger, P FitschaBiomedica Biochimica Acta|January 1, 1984
Is gamma-camera imaging of platelet deposition useful to assess the effectiveness of prostacyclin treatment?P Fitscha, J Kaliman, H SinzingerVASA. Supplementum|January 1, 1989
Pathomechanisms of atherosclerosis beneficially affected by prostaglandin E1 (PGE1)--an updateH Sinzinger, I Virgolini, P FitschaAmerican Journal of Hematology|May 1, 1985
Platelet sensitivity to antiaggregatory prostaglandins (PGE1,D2,I2) in patients with peripheral vascular diseaseP Fitscha, J Kaliman, H SinzingerPostgraduate Medical Journal|April 1, 1987
Effect of prostaglandin E1 on deposition of autologous labelled platelets onto human atherosclerotic lesions in vivoH Sinzinger, J O'Grady, P FitschaProstaglandins, Leukotrienes, and Medicine|September 1, 1982
Hypertension and beneficial treatment with beta-blocking agents does not change the platelet sensitivity to the antiaggregatory prostaglandinsH Sinzinger, P Fitscha, J KalimanPageof 49